General
Preferred name
ANDROGRAPHOLIDE
Synonyms
Andrographis ()
NSC-383468 ()
HMPL-004 ()
HMPL004 ()
P&D ID
PD012040
CAS
5508-58-7
Tags
available
drug candidate
Drug Status
investigational
Max Phase
3.0
Drug indication
Crohn's disease
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Andrographolide is a NF-¦ÊB inhibitor, which inhibits NF-¦ÊB activation through covalent modification of a cysteine residue on p50 in endothelial cells without affecting I¦ÊB¦Á degradation or p50/p65 nuclear translocation. Andrographolide has antiviral effects.
DESCRIPTION Andrographolide (Andrographis)(Andrographis), an irreversible antagonist of NF-??B, has anti-inflammatory and anti-platelet aggregation activities and potential antineoplastic.
DESCRIPTION Andrographolide is a major component of the leaves of the traditionally used medicinal plant Andrographis paniculata (Acanthaceae) . Andrographolide and analogues are being investigated for their potential anti-inflammatory activities , but andrographolide has also shown anti-viral, anti-thrombotic, hepatoprotective and anti-cancer properties . Accumulated evidence indicates that the principal mechanism undelying andrographolide's anti-inflammatory action is inhibition of NF-κB. Additional studies show that Nrf2 activation by andrographolide likely enhances endogenous antioxidant defense mechanisms. Direct covalent interaction with Cys62, and non-covalent binding are both required for andrographolide-induced inhibition of NF-κB p50 . (GtoPdb)
DESCRIPTION Andrographolide (Andrographis)(Andrographis), an irreversible antagonist of NF-κB, has anti-inflammatory and anti-platelet aggregation activities and potential antineoplastic. (TargetMol Bioactive Compound Library)
Cell lines
32
Organisms
9
Compound Sets
10
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugBank
Guide to Pharmacology
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
56
Properties
(calculated by RDKit )
Molecular Weight
350.21
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
0
cLogP
1.96
TPSA
86.99
Fraction CSP3
0.75
Chiral centers
6.0
Largest ring
6.0
QED
0.41
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Autophagy
Influenza Virus
NF-κB
Parasite
SARS-CoV
NF-??
IL1B, IL6, NFKB1, NFKB2, TNF
Pathway
NF-¦ÊB
Microbiology/virology
Anti-infection
MOA
tumor necrosis factor production inhibitor
Source data